BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 24498219)

  • 1. Monocarboxylate transporter 4 facilitates cell proliferation and migration and is associated with poor prognosis in oral squamous cell carcinoma patients.
    Zhu J; Wu YN; Zhang W; Zhang XM; Ding X; Li HQ; Geng M; Xie ZQ; Wu HM
    PLoS One; 2014; 9(1):e87904. PubMed ID: 24498219
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Monocarboxylate transporter 4 predicts poor prognosis in hepatocellular carcinoma and is associated with cell proliferation and migration.
    Gao HJ; Zhao MC; Zhang YJ; Zhou DS; Xu L; Li GB; Chen MS; Liu J
    J Cancer Res Clin Oncol; 2015 Jul; 141(7):1151-62. PubMed ID: 25446815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of FAP suppresses cell proliferation and metastasis through PTEN/PI3K/AKT and Ras-ERK signaling in oral squamous cell carcinoma.
    Wang H; Wu Q; Liu Z; Luo X; Fan Y; Liu Y; Zhang Y; Hua S; Fu Q; Zhao M; Chen Y; Fang W; Lv X
    Cell Death Dis; 2014 Apr; 5(4):e1155. PubMed ID: 24722280
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of the RPL34 gene on the growth and metastasis of oral squamous cell carcinoma cells.
    Dai J; Wei W
    Arch Oral Biol; 2017 Nov; 83():40-46. PubMed ID: 28697409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic value of monocarboxylate transporter 4 in patients with esophageal squamous cell carcinoma.
    Cheng B; Chen X; Li Y; Huang X; Yu J
    Oncol Rep; 2018 Nov; 40(5):2906-2915. PubMed ID: 30226548
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Tspan15 plays a crucial role in metastasis in oral squamous cell carcinoma.
    Hiroshima K; Shiiba M; Oka N; Hayashi F; Ishida S; Fukushima R; Koike K; Iyoda M; Nakashima D; Tanzawa H; Uzawa K
    Exp Cell Res; 2019 Nov; 384(2):111622. PubMed ID: 31518558
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.
    Saito T; Kasamatsu A; Ogawara K; Miyamoto I; Saito K; Iyoda M; Suzuki T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
    PLoS One; 2015; 10(9):e0137923. PubMed ID: 26378920
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lactate Promotes Cancer Stem-like Property of Oral Sequamous Cell Carcinoma.
    Zhao H; Hu CY; Chen WM; Huang P
    Curr Med Sci; 2019 Jun; 39(3):403-409. PubMed ID: 31209810
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Low expression of miR-let-7a promotes cell growth and invasion through the regulation of c-Myc in oral squamous cell carcinoma.
    Luo C; Zhang J; Zhang Y; Zhang X; Chen Y; Fan W
    Cell Cycle; 2020 Aug; 19(15):1983-1993. PubMed ID: 32594835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel miR-365-3p/EHF/keratin 16 axis promotes oral squamous cell carcinoma metastasis, cancer stemness and drug resistance via enhancing β5-integrin/c-met signaling pathway.
    Huang WC; Jang TH; Tung SL; Yen TC; Chan SH; Wang LH
    J Exp Clin Cancer Res; 2019 Feb; 38(1):89. PubMed ID: 30782177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. CiRS-7 functions as a ceRNA of RAF-1/PIK3CD to promote metastatic progression of oral squamous cell carcinoma via MAPK/AKT signaling pathways.
    Dou Z; Gao L; Ren W; Zhang H; Wang X; Li S; Zheng J; Kong X; Chi P; Zhi K
    Exp Cell Res; 2020 Nov; 396(2):112290. PubMed ID: 32956704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crosstalk between Raf-MEK-ERK and PI3K-Akt-GSK3β signaling networks promotes chemoresistance, invasion/migration and stemness via expression of CD44 variants (v4 and v6) in oral cancer.
    Kashyap T; Pramanik KK; Nath N; Mishra P; Singh AK; Nagini S; Rana A; Mishra R
    Oral Oncol; 2018 Nov; 86():234-243. PubMed ID: 30409306
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MiR-148a inhibits oral squamous cell carcinoma progression through ERK/MAPK pathway via targeting IGF-IR.
    Jia T; Ren Y; Wang F; Zhao R; Qiao B; Xing L; Ou L; Guo B
    Biosci Rep; 2020 Apr; 40(4):. PubMed ID: 32202300
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Macrophage migration inhibitory factor promotes the invasion and metastasis of oral squamous cell carcinoma through matrix metalloprotein-2/9.
    Wang SS; Zheng M; Pang X; Zhang M; Yu XH; Wu JB; Gao XL; Wu JS; Yang X; Tang YJ; Tang YL; Liang XH
    Mol Carcinog; 2019 Oct; 58(10):1809-1821. PubMed ID: 31219646
    [TBL] [Abstract][Full Text] [Related]  

  • 15. miR-654-5p Targets GRAP to Promote Proliferation, Metastasis, and Chemoresistance of Oral Squamous Cell Carcinoma Through Ras/MAPK Signaling.
    Lu M; Wang C; Chen W; Mao C; Wang J
    DNA Cell Biol; 2018 Apr; 37(4):381-388. PubMed ID: 29364705
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocarboxylate Transporters MCT1 and MCT4 Regulate Migration and Invasion of Pancreatic Ductal Adenocarcinoma Cells.
    Kong SC; Nøhr-Nielsen A; Zeeberg K; Reshkin SJ; Hoffmann EK; Novak I; Pedersen SF
    Pancreas; 2016 Aug; 45(7):1036-47. PubMed ID: 26765963
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumor protein D54 is a negative regulator of extracellular matrix-dependent migration and attachment in oral squamous cell carcinoma-derived cell lines.
    Mukudai Y; Kondo S; Fujita A; Yoshihama Y; Shirota T; Shintani S
    Cell Oncol (Dordr); 2013 Jun; 36(3):233-45. PubMed ID: 23529586
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Knockdown of Long Non-Coding RNA (lncRNA) Colon Cancer-Associated Transcript-1 (CCAT1) Suppresses Oral Squamous Cell Carcinoma Proliferation, Invasion, and Migration by Inhibiting the Discoidin Domain Receptor 2 (DDR2)/ERK/AKT Axis.
    Sun M; Shen Z
    Med Sci Monit; 2020 Feb; 26():e920020. PubMed ID: 32009633
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    Tang KL; Tang HY; Du Y; Tian T; Xiong SJ
    Biosci Rep; 2019 Jul; 39(7):. PubMed ID: 31213575
    [No Abstract]   [Full Text] [Related]  

  • 20. MIEN1 promotes oral cancer progression and implicates poor overall survival.
    Rajendiran S; Kpetemey M; Maji S; Gibbs LD; Dasgupta S; Mantsch R; Hare RJ; Vishwanatha JK
    Cancer Biol Ther; 2015; 16(6):876-85. PubMed ID: 25996585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.